To further investigate how perturbation of Hpo signaling affects ccRCC cell growth in 2D culture, we treated 786-O cells with different doses of XMU-MP-1 and found that XMU-MP-1 inhibited 786-O cell growth in a dose-dependent manner (Fig. 1G). Here, GFER is linked to nonpapillary renal cell carcinoma.